Prediction of Ovarian Malignancy, in the Presence of Sonographic Pelvic Mass Using Patient History, Sonographic Parameters and Serum Markers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Ovarian Neoplasm
- Sponsor
- HaEmek Medical Center, Israel
- Locations
- 1
- Primary Endpoint
- The risk of malignancy in the presence of pelvic mass demonstrated by sonography.
- Status
- Withdrawn
- Last Updated
- 10 years ago
Overview
Brief Summary
The objective of the study is to create a test that will discriminate between malignant and benign ovarian mass that was diagnosed by ultrasound. The investigators will examine about 800 women and at the end of the study the investigators will combine data from the woman's history, the sonographic characters of the mass and serum biological markers along with the woman's outcome (which means - whether the mass was malignant, benign, or disappeared or remained constant with no intervention).
Detailed Description
Patients that arrive to the sonographic unit of the gynecological department with a diagnosis of ovarian mass will have a sonographic examination that include: Trans-vaginal +- trans-abdominal ultrasound with Doppler and three dimensional sonographic exam. anamnestic data will be collected and serum test for CA 125, HE4 and CEA. The management of the specific patient will be according to the department protocol, regardless the study data. The investigators will collect data about operation outcome and histological results of women that will be operated. Women that won't be operated on will be followed up every 6 months by the study team. At the end of the study a statistical analysis will be made to create a sensitive and specific test for the prediction of malignancy in sonographic diagnosed ovarian mass.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients referred with sonographic diagnosis of pelvic mass
Exclusion Criteria
- •Pregnant women
- •Known gynecologic malignancy
Outcomes
Primary Outcomes
The risk of malignancy in the presence of pelvic mass demonstrated by sonography.
Time Frame: Up to 2 months after recruiting and examining the last participant of the study
Using a combination of the results of US examination, patient's history and serum markers to predict the risk of malignancy in women with pelvic mass demonstrated by sonography.
Secondary Outcomes
- number and kind of operative complications(within one month after operation)
- Reasons for intervention(within one month after operation)
- operative finding and histologic results(within one month after operation)